Yoshiaki Uyama

Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

Hajime Uno, Brian Claggett, Lü Tian et al. · Journal of Clinical Oncology · 2014 · 782 citations · Full text

Public Health, Biostatistics, Oncology +16

STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies

Shirley Wang, Simone Pinheiro, Hua Wei et al. · BMJ · 2021 · 219 citations · Full text

Business, Finance, Risk Management +17

Effects of cyclopiazonic acid, a novel Ca²⁺‐ATPase inhibitor, on contractile responses in skinned ileal smooth muscle

Yoshiaki Uyama, Yuji Imaizumi, Minoru Watanabe · British Journal of Pharmacology · 1992 · 142 citations · Full text

Life Sciences, Pharmacology, Physiology +15

Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions

Shirley Wang, Sushama Kattinakere Sreedhara, Sebastian Schneeweiß et al. · Nature Communications · 2022 · 102 citations · Full text

Pharmacy, Pharmacoeconomics, Evidence-based Practice +15

Establishment of the MID‐NET^® medical information database network as a reliable and valuable database for drug safety assessments in Japan

Mitsune Yamaguchi, Satomi Inomata, Sayoko Harada et al. · Pharmacoepidemiology and Drug Safety · 2019 · 90 citations · Full text

Computing, Biomedical Informatics, Health Informatics +16